Dr. Paul Offit

hang out. Oh, really? Yeah, I mean, certainly varicella hangs out, herpes simplex virus hangs out.

hang out. Oh, really? Yeah, I mean, certainly varicella hangs out, herpes simplex virus hangs out.

hang out. Oh, really? Yeah, I mean, certainly varicella hangs out, herpes simplex virus hangs out.

I don't think so. And here's why. I think that... If you ask, so only two countries recommend it for everybody over six months of age, us and Canada, but Western Europe doesn't, Australia doesn't, the World Health Organization doesn't, so we're really one of only two countries that do this.

I don't think so. And here's why. I think that... If you ask, so only two countries recommend it for everybody over six months of age, us and Canada, but Western Europe doesn't, Australia doesn't, the World Health Organization doesn't, so we're really one of only two countries that do this.

I don't think so. And here's why. I think that... If you ask, so only two countries recommend it for everybody over six months of age, us and Canada, but Western Europe doesn't, Australia doesn't, the World Health Organization doesn't, so we're really one of only two countries that do this.

If you ask people, because I have sort of been nationally saying things like I think we should target high-risk groups, and that's meant that I have managed to alienate the few remaining friends I had actually in this business because I wasn't sort of toeing the line. And so I saw actually Dr. Fauci recently at a meeting and I said, you know, Tony, Dr. Fauci, am I wrong?

If you ask people, because I have sort of been nationally saying things like I think we should target high-risk groups, and that's meant that I have managed to alienate the few remaining friends I had actually in this business because I wasn't sort of toeing the line. And so I saw actually Dr. Fauci recently at a meeting and I said, you know, Tony, Dr. Fauci, am I wrong?

If you ask people, because I have sort of been nationally saying things like I think we should target high-risk groups, and that's meant that I have managed to alienate the few remaining friends I had actually in this business because I wasn't sort of toeing the line. And so I saw actually Dr. Fauci recently at a meeting and I said, you know, Tony, Dr. Fauci, am I wrong?

Actually, I've done it for 30 years. Am I wrong? And he said, no, you're not wrong. I think we should target high-risk groups. The question is how best to do that. And he believed, and he may be right, that when you have a targeted recommendation, that's a nuanced recommendation,

Actually, I've done it for 30 years. Am I wrong? And he said, no, you're not wrong. I think we should target high-risk groups. The question is how best to do that. And he believed, and he may be right, that when you have a targeted recommendation, that's a nuanced recommendation,

Actually, I've done it for 30 years. Am I wrong? And he said, no, you're not wrong. I think we should target high-risk groups. The question is how best to do that. And he believed, and he may be right, that when you have a targeted recommendation, that's a nuanced recommendation,

and therefore a garbled recommendation, that you're much more likely to get those high-risk groups vaccinated if you recommend it for everybody. The problem I have with that is that why do healthy young men need to be vaccinated if they're going to have little benefits? So then the question is, what is the benefit?

and therefore a garbled recommendation, that you're much more likely to get those high-risk groups vaccinated if you recommend it for everybody. The problem I have with that is that why do healthy young men need to be vaccinated if they're going to have little benefits? So then the question is, what is the benefit?

and therefore a garbled recommendation, that you're much more likely to get those high-risk groups vaccinated if you recommend it for everybody. The problem I have with that is that why do healthy young men need to be vaccinated if they're going to have little benefits? So then the question is, what is the benefit?

So if you look at the most recent CDC data from Ruth Link-Gellis, which she presented both to our committee, the FDA committee, and the CDC committee, what she showed is that if you have a match to what you were vaccinated with, to what you were challenged with.

So if you look at the most recent CDC data from Ruth Link-Gellis, which she presented both to our committee, the FDA committee, and the CDC committee, what she showed is that if you have a match to what you were vaccinated with, to what you were challenged with.

So if you look at the most recent CDC data from Ruth Link-Gellis, which she presented both to our committee, the FDA committee, and the CDC committee, what she showed is that if you have a match to what you were vaccinated with, to what you were challenged with.

So for example, you got the XBB15 vaccine last year and you were challenged with XBB15, you decrease your chance of hospitalization, assuming you're in a high-risk group, by about 55% for three months. That's what you do. Beyond that, not as much because you've been previously vaccinated. So it's not as much.

So for example, you got the XBB15 vaccine last year and you were challenged with XBB15, you decrease your chance of hospitalization, assuming you're in a high-risk group, by about 55% for three months. That's what you do. Beyond that, not as much because you've been previously vaccinated. So it's not as much.